PMC:7445716 / 67031-67206 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T565","span":{"begin":91,"end":102},"obj":"Body_part"}],"attributes":[{"id":"A565","pred":"fma_id","subj":"T565","obj":"http://purl.org/sig/ont/fma/fma7184"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T596","span":{"begin":0,"end":4},"obj":"Disease"}],"attributes":[{"id":"A596","pred":"mondo_id","subj":"T596","obj":"http://purl.obolibrary.org/obo/MONDO_0020347"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T589","span":{"begin":97,"end":102},"obj":"http://www.ebi.ac.uk/efo/EFO_0000876"},{"id":"T590","span":{"begin":141,"end":143},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T274","span":{"begin":5,"end":7},"obj":"Chemical"}],"attributes":[{"id":"A17624","pred":"chebi_id","subj":"T274","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"969","span":{"begin":54,"end":69},"obj":"Disease"},{"id":"970","span":{"begin":90,"end":110},"obj":"Disease"}],"attributes":[{"id":"A969","pred":"tao:has_database_id","subj":"969","obj":"MESH:C531747"},{"id":"A970","pred":"tao:has_database_id","subj":"970","obj":"MESH:D018908"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T402","span":{"begin":0,"end":175},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T745","span":{"begin":55,"end":70},"obj":"Phenotype"},{"id":"T746","span":{"begin":91,"end":111},"obj":"Phenotype"}],"attributes":[{"id":"A745","pred":"hp_id","subj":"T745","obj":"http://purl.obolibrary.org/obo/HP_0001349"},{"id":"A746","pred":"hp_id","subj":"T746","obj":"http://purl.obolibrary.org/obo/HP_0007340"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T891","span":{"begin":55,"end":61},"obj":"UBERON:0001456"},{"id":"T892","span":{"begin":97,"end":102},"obj":"UBERON:0002103"}],"text":"AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation"}